Steven H Holtzman - Net Worth and Insider Trading
Steven H Holtzman Net Worth
The estimated net worth of Steven H Holtzman is at least $0 dollars as of 2024-09-20. Steven H Holtzman is the Director of Infinity Pharmaceuticals Inc and owns about 3,945 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $0. Steven H Holtzman is also the EVP Corporate Development of Biogen Inc and owns about 0 shares of Biogen Inc (BIIB) stock worth over $0. Details can be seen in Steven H Holtzman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven H Holtzman has not made any transactions after 2014-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven H Holtzman
Steven H Holtzman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven H Holtzman owns 2 companies in total, including Biogen Inc (BIIB) , and Infinity Pharmaceuticals Inc (INFIQ) .
Click here to see the complete history of Steven H Holtzman’s form 4 insider trades.
Insider Ownership Summary of Steven H Holtzman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BIIB | Biogen Inc | 2014-12-02 | EVP Corp Devel and Strategy |
| INFIQ | Infinity Pharmaceuticals Inc | 2012-05-31 | director & CEO and Assistant Secretary |
Steven H Holtzman Latest Holdings Summary
Steven H Holtzman currently owns a total of 2 stocks. Among these stocks, Steven H Holtzman owns 3,945 shares of Infinity Pharmaceuticals Inc (INFIQ) as of May 31, 2012, with a value of $0 . Steven H Holtzman also owns 0 shares of Biogen Inc (BIIB) as of December 2, 2014, with a value of $0 .
Latest Holdings of Steven H Holtzman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INFIQ | Infinity Pharmaceuticals Inc | 2012-05-31 | 3,945 | 0.00 | 0 |
| BIIB | Biogen Inc | 2014-12-02 | 0 | 199.36 | 0 |
Holding Weightings of Steven H Holtzman
Steven H Holtzman Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven H Holtzman has made a total of 0 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 57,573 shares on May 31, 2012, which brought Steven H Holtzman around $749,025.
According to the SEC Form 4 filings, Steven H Holtzman has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 1,749 shares on December 2, 2014, which brought Steven H Holtzman around $587,052.
Insider Trading History of Steven H Holtzman
- 1
Steven H Holtzman Trading Performance
GuruFocus tracks the stock performance after each of Steven H Holtzman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven H Holtzman is -3.19%. GuruFocus also compares Steven H Holtzman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven H Holtzman within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven H Holtzman's insider trading performs compared to the benchmark.
Performance of Steven H Holtzman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.04 | | | | | |
| Relative Return to S&P 500(%) | 4.1 | | | | | |
Steven H Holtzman Ownership Network
Steven H Holtzman Owned Company Details
What does Biogen Inc do?
Who are the key executives at Biogen Inc?
Steven H Holtzman is the EVP Corp Devel and Strategy of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , Head of Research Jane Grogan , and EVP & Human Resources Ginger Gregory .
Biogen Inc (BIIB) Insider Trades Summary
Over the past 18 months, Steven H Holtzman made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 3,228 shares made by Priya Singhal , a net sale of 2,681 shares made by Ginger Gregory , and a net purchase of 455 shares made by Eric K Rowinsky .
In summary, during the past 3 months, insiders sold 431 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 431 shares. During the past 18 months, 5,909 shares of Biogen Inc (BIIB) were sold and 455 shares were bought by its insiders, resulting in a net sale of 5,454 shares.
Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biogen Inc Insider Transactions
Steven H Holtzman Mailing Address
Above is the net worth, insider trading, and ownership report for Steven H Holtzman. You might contact Steven H Holtzman via mailing address: 115 Powers Road, Sudbury Ma 01776.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
